Patrick Christmas
Chief Legal Officer, Regenexx Bio
Replay available
REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call
REGENXBIO Inc. (NASDAQ: RGNX) Q1 2026 earnings conference call, held 2026-05-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Curran Simpson
President & CEO, Regenexx Bio
Dr. Steve Bacola
Chief Medical Officer, Regenexx Bio
Dr. Aravindan Virapandian
Investigator ("Dr. Panda")
Dr. Diana Castro
Investigator
Dr. Carolina Tessie Rocha
Investigator
Judah Frommer
Analyst, Morgan Stanley
Mani Furhar
Analyst, Leerink Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Regenxbio Inc..
Replay transcript excerpt
WEBVTT 00:00:00.233 -- 00:00:05.509 Welcome everyone to the Regenexx BIO RGX 202 Topline Pivotal Data 00:00:05.509 -- 00:00:10.525 Webcast. At this time, I'd like to turn the conference over to Patrick Christmas, 00:00:10.525 -- 00:00:15.286 Chief Legal Officer of Regenexx BIO. Please go ahead. 00:00:15.286 -- 00:00:17.630 Good morning, and thank you for joining us today. 00:00:17.630 -- 00:00:22.638 Earlier this morning, Regenexx Bio released pivotal, top-line data from 00:00:22.638 -- 00:00:25.764 the Affinity Duchenne trial of RGX202, 00:00:25.764 -- 00:00:29.530 as well as financial and operating results for the first quarter ended March 31, 2026. 00:00:29.530 -- 00:00:30.953 The 00:00:30.953 -- 00:00:35.076 press releases are available on our website at www.regenexxbio.com. 00:00:35.300 -- 00:00:39.587 Today's webcast will include forward-looking statements regarding our financial outlook 00:00:39.587 -- 00:00:42.231 in addition to regulatory and product development plans. 00:00:42.231 -- 00:00:46.638 These forward-looking statements are subject to risks and uncertainties that may cause 00:00:46.638 -- 00:00:51.586 actual results to differ from those forecasted and can be identified by words such as 00:00:51.586 -- 00:00:56.894 expect, plan, will, may, anticipate, believe, should, intend, and other words 00:00:56.894 -- 00:01:00.479 of similar meaning. Any such forward-looking statements are not guarantees of future 00:01:00.479 -- 00:01:03.724 performance and involve certain risks and uncertainties. 00:01:03.724 -- 00:01:08.971 These risks are described in the risk factors and the management's discussion and analysis 00:01:08.971 -- 00:01:13.717 sections of Regenexx Bio's annual report on Form 10-K for the full year ended December 00:01:13.717 -- 00:01:19.005 3...